NRx Pharmaceuticals (NRXP) Provides Business Update, Reports Q2, Focuses on Reactivation & Advancement of Psychiatry Franchise

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. IBM
3. MU
4. ACN
5. PRIM
6. META
7. DPZ
8. NAVN
9. NVDA
10. DFTX

Go back to NRx Pharmaceuticals (NRXP) Provides Business Update, Reports Q2, Focuses on Reactivation & Advancement of Psychiatry Franchise
(NASDAQ: NRXP) Delayed: 3.90 --0 (-0%)
Previous Close $3.90    52 Week High $ 
Open $3.90    52 Week Low $ 
Day High $3.90    P/E N/A 
Day Low $3.90    EPS $ 
Volume 36,783